US Food and Drug Administration

US Food and Drug Administration News

Pfizer to buy Hospira for $15 bn

Pfizer’s offer of $90 per share represents a premium of 39 per cent to Hospira stock’s close on Wednesday.

Guilty pleasures

An apple or a brownie? If you choose the former 100-calorie food over the latter 800-calorie one, how do you quantify the loss of pleasure?

Advertising

Iraqi man gets a ‘mechanical’ heart in landmark surgery

Approved by the US Food and Drug Administration (FDA), the device is an external, wearable system

SC notice to Centre, Ranbaxy on plea for cancelling its licence

Ranbaxy insisted drugs sold by it in the Indian market are safe and effective and the company complies with country’s regulations.

Ranbaxy recalls few batches of generic Lipitor tablets in US

The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs to the United States.

US 'not targeting' Indian pharma companies, says FDA chief

While allaying apprehensions that the US is not targeting Indian companies, they said its a routine inspection followed across countries.

Advertising

Pharma Inc calls for alignment with US rules

Over 25 per cent of the generics imported by the US come from India.

USFDA stops all Ranbaxy drugs, fourth plant banned

This is the fourth facility of the generic drug manufacturer to be charged by the US health regulator with such violations and the move stops all drug shipments from the company to the US.

Ranbaxy posts loss in Q3 on forex woes

The company had pleaded guilty in May to US felony charges related to drug safety and agreed to a record $500 million in fines.

USFDA increases inspections of drug facilities in India

The US health regulators is also recruiting and training additional drugs investigators in India.

US Food and Drug Administration Videos

Implant files: How medical devices that are recalled in the US are still in use in India

The Indian Express-ICIJ investigation finds that at least 57 medical devices, many used in critical care, were being sold in India when the US Food and Drug Administration (FDA) clamped down on them for a range of faults over the last two years.

Advertising